Bioethics 24 (6):273-283 (2010)
Authors |
|
Abstract |
It is by now no secret that some scientific articles are ghost authored – that is, written by someone other than the person whose name appears at the top of the article. Ghost authorship, however, is only one sort of ghosting. In this article, we present evidence that pharmaceutical companies engage in the ghost management of the scientific literature, by controlling or shaping several crucial steps in the research, writing, and publication of scientific articles. Ghost management allows the pharmaceutical industry to shape the literature in ways that serve its interests. This article aims to reinforce and expand publication ethics as an important area of concern for bioethics. Since ghost-managed research is primarily undertaken in the interests of marketing, large quantities of medical research violate not just publication norms but also research ethics. Much of this research involves human subjects, and yet is performed not primarily to increase knowledge for broad human benefit, but to disseminate results in the service of profits. Those who sponsor, manage, conduct, and publish such research therefore behave unethically, since they put patients at risk without justification. This leads us to a strong conclusion: if medical journals want to ensure that the research they publish is ethically sound, they should not publish articles that are commercially sponsored.
|
Keywords | publication ethics sponsorship bias research ethics ghost management |
Categories | (categorize this paper) |
Reprint years | 2010 |
DOI | 10.1111/j.1467-8519.2008.01702.x |
Options |
![]() ![]() ![]() ![]() |
Download options
References found in this work BETA
No references found.
Citations of this work BETA
“Author TBD”: Radical Collaboration in Contemporary Biomedical Research.Rebecca Kukla - 2012 - Philosophy of Science 79 (5):845-858.
Scientists’ Conceptions of Good Research Practice.Nora Hangel & Jutta Schickore - 2017 - Perspectives on Science 25 (6):766-791.
Credibility Engineering in the Food Industry: Linking Science, Regulation, and Marketing in a Corporate Context.Bart Penders & Annemiek P. Nelis - 2011 - Science in Context 24 (4):487-515.
The Disposable Author:How Pharmaceutical Marketing Is Embraced Within Medicine's Scholarly Literature.Alastair Matheson - 2016 - Hastings Center Report 46 (4):31-37.
On the Conditions for Objectivity : How to Avoid Bias in Socially Relevant Research.Saana Jukola - unknown
View all 8 citations / Add more citations
Similar books and articles
Conflict of Interest and Medical Publication.Marcus M. Reidenberg - 2002 - Science and Engineering Ethics 8 (3):455-457.
The Authorless Paper: The ICMJE’s Definition of Authorship is Illogical and Unethical.David Shaw - 2011 - British Medical Journal 343 (7831):999.
Teaching Authorship and Publication Practices in the Biomedical and Life Sciences.Francis L. Macrina - 2011 - Science and Engineering Ethics 17 (2):341-354.
Analytics
Added to PP index
2009-02-17
Total views
63 ( #158,459 of 2,411,815 )
Recent downloads (6 months)
1 ( #538,761 of 2,411,815 )
2009-02-17
Total views
63 ( #158,459 of 2,411,815 )
Recent downloads (6 months)
1 ( #538,761 of 2,411,815 )
How can I increase my downloads?
Downloads